Emmanuel J. Simons
Chief Executive Officer at AKOUOS
Emmanuel J. Simons active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AKOUOS | Chief Executive Officer | 2015-12-31 | - |
| Founder | 2015-12-31 | - |
Career history of Emmanuel J. Simons
Training of Emmanuel J. Simons
| Harvard Business School | Masters Business Admin |
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Executive Officer | 1 |
| Founder | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Emmanuel J. Simons
- Experience
